Interview: Medtech’s Unique Market-Access Routes Demand Tailored Response For EU-Wide HTA
The European Commission is looking at initiatives for employing health technology assessment at the EU level. But the medtech industry is concerned that its own specific market-access routes are being overlooked while the commission focuses too narrowly on solutions more suited to the pharma industry. MedTech Europe’s Yves Verboven explains the industry's case in an interview.
Register for our free email digests: